We are monitoring the impact of COVID-19 on North America Non-Invasive Prenatal Testing Market Get in touch with us for detailed analysis Know More
Share on

North America Non-Invasive Prenatal Testing Market Research Report - Segmented By Instruments, Method, Application, End User, & Country (The United States, Canada & Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2701
Pages: 150

North America Non-Invasive Prenatal Testing Market Size (2022 to 2027)

The size of the North American Non-Invasive Prenatal Testing Market is estimated to value USD 1.55 billion by 2027 and USD 0.73 billion in 2022, growing at a CAGR of 16.20% during the forecast period.

The market for the non-invasive prenatal testing market is most likely to be driven by a rising preference for non-invasive techniques over invasive methods and growing awareness of non-invasive prenatal testing. Also, the high risk of chromosomal abnormalities with growing maternal age is expected to drive the market. Moreover, improving reimbursement scenarios for Non-Invasive Prenatal Testing and growing product usage in new applications is influencing the market growth in the region. Additionally, advancements in current tests in enhanced functionalities, better chemistry, and bioinformatics analysis are expected to drive market growth.

The benefits of these tests over more comprehensive and invasive procedures like amniocentesis and chronic villus collection have boosted NIPT testing usage. These benefits are more likely to promote the acceptance of such treatments, resulting in the market's rapid growth.

Furthermore, technological advancements in the detection of monogenic diseases enhance market revenue. Progenity, Inc., for example, introduced Resura in April 2019 to enhance its portfolio in contrast to other competitive tests on the market. Resura is a prenatal test for a monogenic illness that utilizes sequencing-based non-invasive cell-free DNA technology.

The American College of Obstetricians and Gynecologists (ACOG) collaborated with the Society for Maternal-Fetal Medicine (SMFM) to release recommendations on aneuploidy screening options, which prompted this coverage (SMFM). One of the market's main driving forces is improving payment policies for ordinary and low-risk pregnancies. For example, Natera announced in December 2020 that their non-invasive prenatal testing (NIPT) would be covered by the most extensive U.S. health plan, Aetna, for all pregnancies.

Owing to the rise in genetic diseases, increased awareness of early fetal testing, and growing maternal age, the market demand for non-invasive prenatal testing is projected to rise over the forecast period. In addition, the developed countries such as the United States and Canada have witnessed advanced healthcare infrastructure, technological advancement in the healthcare sector, which are expected to provide lucrative growth opportunities for the new market entrants.

However, a dearth of skilled professionals is restraining the growth of this market. Also, a lack of test accessibility, ethical issues, and strict government restrictions are only a few reasons that will limit the North American NIPT market's growth.

This research report on the North American Non-Invasive Prenatal Testing Market has been segmented and sub-segmented into the following categories.

By Instruments: 

  • Ultrasound
  • NGS
  • PCR
  • Microarray

By Method: 

  • FCMB
  • Cf-DNA

By Application: 

  • Trisomy
  • Microdeletion
  • Genetics
  • Rh Factor

By End User: 

  • Hospitals
  • Diagnostic Labs

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, North America took the major chunk of the Global Non-Invasive Prenatal Testing Market share in 2020, with the U.S. accounting for a major share.

Globally, North America dominated the Non-Invasive Prenatal Testing Market and accounted for the revenue share of over 45.9 % in 2020. The market growth in the region is attributed to the technological advancements in the healthcare sector, favourable reimbursement policies, and rising preference for non-invasive techniques over invasive methods. Although the United States lacks national consensus policies on NIPT implementation, it is extensively embraced across the country, resulting in North America's dominance. As a result, in the North American regional market, the United States dominated the market growth and held the highest share over the forecast period. The country's major companies concentrate on inorganic strategies with the industry's leading players to enhance their research and commercialization capabilities, which are projected to generate substantial market revenue.

Furthermore, major insurance companies' recent inclusion of NIPT in their coverage plans is expected to promote market growth in the United States. In addition, Illumina won a patent infringement case against Roche's Ariosa Diagnostics (Roche) in June 2019. on the other hand, the Canadian Non-Invasive Prenatal Testing Market is anticipated to account for a moderate share and contribute to the regional market growth. 

KEY MARKET PLAYERS:

A few of the prominent companies operating in the North America Non-Invasive Prenatal Testing Market profiled in the report are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Billion)
  2. North America Ultrasound Market, By Region, From 2022 - 2027 (USD Billion)
  3. North America NGS Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America PCR Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America Microarray Market, By Region, From 2022 - 2027 (USD Billion)
  6. North America Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Billion)
  7. North America FCMB Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America cf-DNA Market, By Region, From 2022 - 2027 (USD Billion)
  9. North America Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Billion)
  10. North America Trisomy Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America Microdeletion Market, By Region, From 2022 - 2027 (USD Billion)
  12. North America Genetics Market, By Region, From 2022 - 2027 (USD Billion)
  13. North America Rh Factor Market, By Region, From 2022 - 2027 (USD Billion)
  14. North America Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Billion)
  15. North America Hospital Market, By Region, From 2022 - 2027 (USD Billion)
  16. North America Diagnostic Labs Market, By Region, From 2022 - 2027 (USD Billion)
  17. United States Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Billion)
  18. United States Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Billion)
  19. United States Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Billion)
  20. United States Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Billion)
  21. Canada Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Billion)
  22. Canada Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Billion)
  23. Canada Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Billion)
  24. Canada Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample